The global Capecitabine Market is entering a high-growth phase as oncology treatments shift from intravenous infusions to convenient, oral home-care regimens. Capecitabine—a fluoropyrimidine carbamate—is a prodrug that converts into the active cancer-fighting agent 5-FU within the tumor. In 2025, this medication remains a cornerstone for treating gastrointestinal and breast cancers, p... https://logcla.com/blogs/947640/Low-Zero-Sugar-Energy-Drinks-Segment-Dominance-and-Revenue-Projection